NEWS
Vivanti and Bioveritas Partners join forces to strengthen how Medical Affairs teams apply evidence
Senior pharmaceutical expertise meets AI-supported practice, helping leaders identify gaps in scientific judgement that knowledge scores alone may miss.
The question every Medical Affairs leader...
Seamless 2D to 3D Cell Culture
Amsbio announce StemFit™ Basic05, a next-generation, animal origin-free medium designed for scalable human pluripotent stem cell (hPSC) manufacturing.
Compatible with both 2D adherent and 3D...
Biotechnology
AI Can’t Create What It Doesn’t Know: Why Inputs Matter
AI can analyse evidence faster than ever, but primary research with customers still creates the evidence pharmaceutical companies require for strategic decision making, says...
The biggest barrier to AI in life sciences isn’t the AI
Only 12% of agentic AI initiatives reached production over the past year. The challenge isn’t the technology, but ensuring AI can operate within highly...
Drug Discovery
Are animal models limiting progress in product development?
Toxicity Testing in the 21st Century (TT21C) is helping to reshape biological testing by focusing on the mechanisms that drive toxicity and disease.
Matt Stevenson,...
Turbocharging ‘good’ viruses to destroy bacteria
Scientists at the University of Leicester have developed a new technique that will turbocharge the use of phages for medicinal purposes.
The pioneering technique uses...
